01 Nov, 2024 Life sciences M&A roundup: October 2024 By Ross McNaughton Sarah Cole We have seen a general plateauing of biotech M&A in the last few months, but we've kept tabs on a few deals of note in October, keeping...
31 Oct, 2024 Employee Ownership Trusts - a reformed era? By Katie Lewis Hidden deep among the Budget talk on 30 October 2024, the Government published their long awaited response to the consultation on...
31 Oct, 2024 AI matters | Financial services round-up (October 2024) By Daniel Hirschfield AI in investment management Current and future use cases of AI in investment management are the subject of the third and final report...
23 Oct, 2024 Ofcom publishes revised Online Safety compliance timetable By Debbie Heywood On 17 October 2024, nearly a year after the UK's Online Safety Act (OSA) became law, Ofcom published a revised timeline for OSA...
23 Oct, 2024 Celebrating the launch of our Trophy Assets Guide By Nick Warr It was fantastic to see so many friendly faces at our Trophy Assets Guide launch party. Held at the Wallace Collection in London, we were...
18 Oct, 2024 "Arrangements" that disqualify new EMI option grants: updated HMRC guidance By Elliot Michaelson Taylor HMRC has released updated guidance which impacts the grant of new Enterprise Management Incentive (EMI) options. The guidance sets out...
18 Oct, 2024 Cyber seminar panel discussion: protecting your reputation during a cyber-attack By Mary Rendle Beth Maundrill, Editor at Infosecurity Magazine, Jenny Davey, Partner at FGS, and Adam Speker, Barrister at 5RB, sat down to discuss the...
15 Oct, 2024 Interpretation of Art 22 EUMR quashed by Court of Justice By Paolo Palmigiano On 3 September 2024, the Court of Justice of the European Union (CJEU) annulled a decision by the European Commission regarding the...
15 Oct, 2024 AI and cyber security By Andi Terziu Jo Joyce At our recent cyber seminar co-hosted with PR crisis specialists from FGS Global, a panel made up of distinguished professionals...
15 Oct, 2024 Novartis and patent litigation to stop rival By Paolo Palmigiano Novartis has avoided antitrust charges in the EU and Switzerland after both regulators concluded their investigations into the company’s...
11 Oct, 2024 The changing cyber landscape – current threats, new laws, regulations and insurance By Edward Spencer Taylor Wessing's Data and Cyber team recently hosted a Cyber Strategy Seminar in collaboration with FGS Global, a leading crisis...
09 Oct, 2024 UK government launches new Regulatory Innovation Office to reduce red tape By Debbie Heywood On 8 October 2024, acting on a manifesto commitment, the UK's Department for Science, Innovation and Technology, announced the launch of...